Navigation Links
Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
Date:7/16/2008

NEWPORT NEWS, Va., July 16 /PRNewswire/ -- Dilon Technologies, makers of a gamma imaging system optimized for early breast cancer detection, today announced a three-year agreement with Amerinet, a leading national group purchasing organization. Effective immediately, the relationship offers Amerinet's 26,000 acute and non-acute healthcare providers and their patients' access to the Dilon 6800 Gamma Camera, used in detecting and diagnosing very early stage breast cancers.

"Dilon Technologies is committed to enhancing the standard of healthcare in communities across the nation, said David Rom, National Accounts Director for Dilon. "This strategic partnership with Amerinet will help physicians with difficult-to-diagnose patients and continue to aid in the fight against breast cancer."

The Dilon 6800 performs a molecular breast imaging technique called Breast-Specific Gamma Imaging (BSGI), which can detect lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunct procedure to mammography and ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a radioactive tracing agent that is absorbed by all the cells in the body. Cancerous cells in the breast, due to their increased rate of metabolic activity, absorb a greater amount of the tracing agent than normal healthy cells, and generally appear as "hot spots" on the BSGI image.

Amerinet strategically partners with healthcare providers to reduce costs and improve the delivery of quality care. Supported by a team of clinical, data and supply chain experts, Amerinet offers a suite of tools, programs and services including a comprehensive and competitive portfolio that delivers practical solutions to address members' specific needs. To learn more, visit http://www.amerinet-gpo.com.

About Dilon Technologies

Dilon Technologies is bringing inn
'/>"/>

SOURCE Dilon Technologies
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Dilon Technologies Announces National Agreement with MedAssets
2. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
3. Dilon Technologies Appoints New VP of Sales & Business Development
4. Dilon Technologies Explores Improvements in Molecular Breast Imaging
5. Wound Management Technologies, Inc. Announces Filing of a 510K
6. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
7. Althea Technologies Appoints E.J. Brandreth to Vice President of Quality and Regulatory
8. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing And The Importance Of New Medicare-Related E-Prescribing Legislation
9. VNUS Medical Technologies to Report Second-Quarter 2008 Results and Webcast Teleconference on July 29
10. Cadient Groups GEL Interactive Technologies Celebrates Major Milestones for Immerse Exhibit Platform: 500th Exhibit Implementation and 250,000th Healthcare Professional Registered with Immerse Exhibit Platform
11. VNUS Medical Technologies, Inc. Announces Board of Director Resignation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Lawyers from The Healy Law Firm s... Illinois on behalf of man rendered an incomplete ...IL (Lexis Nexis) November 30, 2009 -- A Cook Count...r of an Irish immigrant carpenter, 22 years old at...endered an incomplete quadriplegic. The verdict, ...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Three decades ...were being swallowed by children, prompting a swit... presented today at the annual meeting of the Radi...t the new tabs are still potentially unsafe. ,,... beverage can construction in the U.S. was to elim...
(Date:11/30/2009)... Middle-aged men and women who engage in high lev...g damage to their knees and increasing their risk ... today at the annual meeting of the Radiological S...est that people with higher physical activity leve...rmalities and, thus, at higher risk for developing...
(Date:11/30/2009)...S Nov. 30, 2009 UT Southwestern Medical Center r...p families stave off complications associated with... December issue of Pediatrics, suggest that inte...ic children who have received specialized topical ...attacks, emergency room visits and missed adult wo...
(Date:11/29/2009)... The Academy of General Dentistry ...ounty CA, received the Mastership Award during the...D members, commitment to excellence in dental educ...,100 hours of approved continuing dental education... hours dedicated to hands-on skills and techniques...
Breaking Medicine News(10 mins):Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 3Health News:Beverage Can Stay-Tabs Pose Swallowing Risk 2Health News:Too much physical activity may lead to arthritis 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2
...in automated,medication management, today unveiled...t remote dispensing system designed exclusively fo...eir care. , The company made the announcemen...stem are operating in Texas, and each,InSite unit ...
...tional, Inc. (Amex: BUF ), announced today the C...scuss current business conditions on Tuesday,Novem... number is,(866) 901-2585. The international call ... ctrego@minrad.com , (716) 85...
...e for anti-aging drug trials, study says , ...biomarkers that are highly accurate in determining...hers at California,s Buck Institute for Age Resear... changes in gene expression, and complex computer ...
...., the makers of,Carmex(R) lip balms, today unveil... association with the new site,s launch, the compa...rmex.com. , "We know that Carmex users are s...flects this lifestyle and enables our,customers to...
...ce advertising,agency, recently received two prest...dia (MM&M), a leading healthcare publication. ... and effectiveness in healthcare marketing. Mango...m/cgi-bin/prnh/20081119/AQW573 ) , (Logo: ...
... Larry King,turns 75. In conjunction with his birt...alth Solutions and the LAC+USC Camino de Salud Net...ala in Los Angeles. The,Foundation, which provides...to quintuple-bypass surgery. He decided then, he w...
Other Medicine News:Health News:Talyst Unveils InSite for Long-Term Care 2Health News:Talyst Unveils InSite for Long-Term Care 3Health News:Researchers ID Suite of Genes in Aging Process 2Health News:Carma Laboratories Launches New Carmex(R) Web Site; Unveils Top 10 Reasons for a Virtual Visit 2Health News:Mangos Wins Two Gold Awards 2Health News:The King of Hearts Helps Others Follow a Healthy Road 2Health News:The King of Hearts Helps Others Follow a Healthy Road 3Health News:The King of Hearts Helps Others Follow a Healthy Road 4
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Med...shed ultrasound solutions, will showcase leading u...p, GE Logiq I and Siemens X300 Premium Edition dur...ety of North America (RSNA) conference, being held...sin-based MedPro Imaging markets ultrasound produc...
(Date:11/30/2009)..., , WAYNE, N.J. and CHICAGO, Nov. 30 /PRN...and Annual Meeting of the Radiological Society o...ticals Inc. announced the enrollment of the first ...al to evaluate the efficacy and safety of florbeta...beta-Amyloid plaques in the brain, which are a pat...
(Date:11/30/2009)..., , INDIANAPOLIS, Nov. 30 /PRNews...ration (FDA) has approved Cymbalta® (duloxeti...ed anxiety disorder (GAD) in adults, Eli Lilly and...nce generalized anxiety disorder can be a chronic ...tients find a treatment option that is effective i...
Breaking Medicine Technology:MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 1Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 2Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 3Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 4Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 1Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 2Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 3Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 4Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 1Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 2Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 3Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 4
...nificance , , ISELIN, N.J., Nov. 19 Pharmos...ults from its Phase 2a clinical trial of its topic...ulated with 3% Diclofenac Diethanolamine. , , ...cebo-controlled study evaluated the safety and eff...e NanoEmulsion cream in 104 patients with chronic ...
...lopment and,manufacturing organization for sterile...f its contract facility in Delaware. Isogen was fo...y and capacity problems commonly,associated with t...nd,early-stage commercial sterile filling market s...lion and four years to develop sterile,manufacturi...
Other Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: